Daniel E. Geffken - Insider Trading & Ownership

Entity
Individual
Location
Damonmill Square, Suite 6 A, Concord, MA
Summary
The estimated net worth of Daniel E. Geffken is at least $138K dollars as of May 20, 2024. Daniel E. Geffken is the Chief Financial Officer of PHOENIX BIOTECH ACQUISITION CORP. and owns shares of CERO THERAPEUTICS HOLDINGS, INC. (CERO) stock worth about $100K. Daniel E. Geffken is the INTERIM CFO of Eloxx Pharmaceuticals, Inc. and owns shares of Eloxx Pharmaceuticals, Inc. stock worth about $36K. Daniel E. Geffken is the Director of WINDTREE THERAPEUTICS INC /DE/ and owns shares of WINDTREE THERAPEUTICS INC /DE/ (WINT) stock worth about $2.22K.
All Insider Reports
All Insider Reports

Ownership of Daniel E. Geffken

Insider Transactions Reported by Daniel E. Geffken:

* An asterisk sign (*) next to the price indicates that the price is likely invalid.